Category: Judicial

From the Publisher & CEO: The Big Question on the Minds of Every 340B Stakeholder

August 24, 2023 Rich Daly, Editor in Chief Views

340B stakeholders are anticipating two major contract pharmacy judicial rulings, including one from the Court of Appeals for the District of Columbia.

Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Schedules Arguments in Challenge to Arkansas Contract Pharmacy Law

August 22, 2023 William Newton, Associate Editor/Senior Writer Views

Two states have laws protecting 340B contract pharmacy arrangements and two others have passed 340B reporting requirements.

A federal appeals court has scheduled oral arguments for September in a case challenging Arkansas’ protections for 340B providers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Asks Court to Deny Injunction Against Medicare Drug Price Negotiations

August 17, 2023 Tom Mirga, Editor at Large Views

HHS asked the U.S. District Court in Dayton, Ohio to deny a preliminary injunction that would prevent Medicare drug price negotiations.

The U.S. Department of Health and Human Services (HHS) asked a federal court to deny a preliminary injunction sought by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Major Drug Company Sues Louisiana Over 340B Contract Pharmacy Law

August 15, 2023 William Newton, Associate Editor/Senior Writer Views

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.

Drug manufacturer AstraZeneca, one of the first companies to place restrictions on 340B discounts in the contract pharmacy setting, has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Five Major Drug Makers Oppose Health Center’s Legal Challenge to 340B Patient Definition

August 8, 2023 Tom Mirga, Editor at Large Views

AbbVie, BMS, Lilly, and Merck jointly asked a federal district court to dismiss a health center’s challenge to the 340B patient definition. Drug maker Janssen asked the same separately.

Drug makers AbbVie, Bristol Myers Squibb, Janssen, Lilly, and Merck asked a federal district court in South Carolina on Friday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana’s New 340B Contract Pharmacy Law Goes Into Effect Today; PhRMA Sues and Teva Suspends its Restrictions in the State

August 1, 2023 William Newton, Associate Editor/Senior Writer Views

Brand drug trade group PhRMA is suing Louisiana over its law protecting 340B contract pharmacy arrangements.

Today is the first day of Louisiana’s new law protecting 340B program contract pharmacy arrangements and there have already been [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Tells Federal Court it Still Stands by its 340B Patient Definition in Closely Watched Case

August 1, 2023 Tom Mirga, Editor at Large Views

HRSA says it stands by its patient definition in Genesis' federal lawsuit seeking a far broader definition.

The U.S. Health Resources and Services Administration (HRSA) still stands by its 340B program patient definition, the agency said in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

July 20, 2023 William Newton, Associate Editor/Senior Writer Views

Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.

Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Judge Rejects 340B Provider Challenge to California Medicaid Drug Payment Shift

July 18, 2023 Rich Daly, Editor in Chief Views

A federal district judge in Sacramento, Calif., dismissed a lawsuit on July 17 aimed at reversing the state’s transfer of Medicaid managed care drugs benefits to Medicaid fee for service.

A federal district judge in Sacramento, Calif., recently dismissed a lawsuit aimed at reversing the state’s January 2022 transfer of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

U.S. Chamber of Commerce Asks Court to Pause Medicare Drug Price Negotiations

July 18, 2023 William Newton, Associate Editor/Senior Writer Views

The U.S. Chamber of Commerce asked a federal district court last week for a preliminary injunction against Medicare drug price negotiation.

The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live